JWM
NVAX icon

JPL Wealth Management’s Novavax NVAX Stock Holding History

JPL Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114 Buy
+12
New +$108 ﹤0.01% 1605

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

JPL Wealth Management's NVAX Position: Q2 2026 in Review

JPL Wealth Management opened a new position in Novavax (NVAX) in Q2 2026: 12 shares worth $114. The stake represents ﹤0.01% of the portfolio and ranks #1605 among its holdings.

266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • JPL Wealth Management held 12 shares of Novavax worth $114 as of Q2 2026.
  • Novavax was a new JPL Wealth Management position in Q2 2026.
  • Novavax made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1605 holding.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.